<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/10451/4367">
    <title>DSpace Collection:</title>
    <link>http://hdl.handle.net/10451/4367</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/10451/4550" />
      </rdf:Seq>
    </items>
    <dc:date>2013-05-25T23:05:28Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/10451/4550">
    <title>Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning</title>
    <link>http://hdl.handle.net/10451/4550</link>
    <description>Title: Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning
Authors: Graça, Luís; Daley, Stephen; Fairchild, Paul J.; Cobbold, Stephen P; Waldmann, Herman
Abstract: Background: A major challenge in the application of marrow transplantation as a route to&#xD;
immunological tolerance of a transplanted organ is to achieve hematopoietic stem cell (HSC)&#xD;
engraftment with minimal myelosuppressive treatments.&#xD;
Results: We here describe a combined antibody protocol which can achieve long-term&#xD;
engraftment with clinically relevant doses of MHC-mismatched bone marrow, without the need for&#xD;
myelosuppressive drugs. Although not universally applicable in all strains, we achieved reliable&#xD;
engraftment in permissive strains with a two-stage strategy: involving first, treatment with anti-CD8&#xD;
and anti-CD4 in advance of transplantation; and second, treatment with antibodies targeting CD4,&#xD;
CD8 and CD40L (CD154) at the time of marrow transplantation. Long-term mixed chimerism&#xD;
through co-receptor and co-stimulation blockade facilitated tolerance to donor-type skin grafts,&#xD;
without any evidence of donor-antigen driven regulatory T cells.&#xD;
Conclusion: We conclude that antibodies targeting co-receptor and co-stimulatory molecules&#xD;
synergise to enable mixed hematopoietic chimerism and central tolerance, showing that neither&#xD;
cytoreductive conditioning nor 'megadoses' of donor bone marrow are required for donor HSC&#xD;
to engraft in permissive strains.
Description: © 2006Graca et al; licensee BioMed Central Ltd.&#xD;
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),&#xD;
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</description>
    <dc:date>2006-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

